Arcadia Biosciences (RKDA) Competitors $3.66 +0.15 (+4.27%) Closing price 09/18/2025 03:48 PM EasternExtended Trading$3.66 +0.00 (+0.14%) As of 09/18/2025 06:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock RKDA vs. CEAD, SEED, EDBL, IVP, ORIS, SISI, SANW, YTEN, AAGR, and AAGRWShould you be buying Arcadia Biosciences stock or one of its competitors? The main competitors of Arcadia Biosciences include CEA Industries (CEAD), Origin Agritech (SEED), Edible Garden (EDBL), Inspire Veterinary Partners (IVP), Oriental Rise (ORIS), SHINECO (SISI), S&W Seed (SANW), Yield10 Bioscience (YTEN), African Agriculture (AAGR), and African Agriculture (AAGRW). These companies are all part of the "agriculture" industry. Arcadia Biosciences vs. Its Competitors CEA Industries Origin Agritech Edible Garden Inspire Veterinary Partners Oriental Rise SHINECO S&W Seed Yield10 Bioscience African Agriculture African Agriculture Arcadia Biosciences (NASDAQ:RKDA) and CEA Industries (NASDAQ:CEAD) are both small-cap agriculture companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, valuation, dividends, profitability, risk, earnings, analyst recommendations and institutional ownership. Do institutionals & insiders believe in RKDA or CEAD? 17.7% of Arcadia Biosciences shares are owned by institutional investors. Comparatively, 21.6% of CEA Industries shares are owned by institutional investors. 1.8% of Arcadia Biosciences shares are owned by insiders. Comparatively, 4.8% of CEA Industries shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Which has preferable earnings and valuation, RKDA or CEAD? CEA Industries has lower revenue, but higher earnings than Arcadia Biosciences. CEA Industries is trading at a lower price-to-earnings ratio than Arcadia Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioArcadia Biosciences$5.05M0.99-$7.04M-$4.28-0.86CEA Industries$3.28M3.50-$2.91M-$4.23-3.39 Is RKDA or CEAD more profitable? CEA Industries has a net margin of -118.08% compared to Arcadia Biosciences' net margin of -139.36%. CEA Industries' return on equity of -27.79% beat Arcadia Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Arcadia Biosciences-139.36% -34.75% -20.91% CEA Industries -118.08%-27.79%-24.75% Does the media favor RKDA or CEAD? In the previous week, CEA Industries had 1 more articles in the media than Arcadia Biosciences. MarketBeat recorded 1 mentions for CEA Industries and 0 mentions for Arcadia Biosciences. Arcadia Biosciences' average media sentiment score of 1.00 beat CEA Industries' score of -0.71 indicating that Arcadia Biosciences is being referred to more favorably in the media. Company Overall Sentiment Arcadia Biosciences Positive CEA Industries Negative Which has more volatility and risk, RKDA or CEAD? Arcadia Biosciences has a beta of 0.57, suggesting that its stock price is 43% less volatile than the S&P 500. Comparatively, CEA Industries has a beta of 0.54, suggesting that its stock price is 46% less volatile than the S&P 500. SummaryCEA Industries beats Arcadia Biosciences on 8 of the 13 factors compared between the two stocks. Get Arcadia Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RKDA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RKDA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RKDA vs. The Competition Export to ExcelMetricArcadia BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.79M$3.12B$5.77B$10.28BDividend YieldN/A2.37%5.74%4.64%P/E Ratio-0.8621.2276.8626.97Price / Sales0.99472.24544.13128.91Price / CashN/A45.3237.1760.63Price / Book0.809.6913.836.37Net Income-$7.04M-$52.92M$3.29B$271.46M7 Day Performance7.46%2.19%1.57%2.53%1 Month Performance-17.01%8.96%6.86%9.42%1 Year Performance24.91%10.84%81.58%30.16% Arcadia Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RKDAArcadia Biosciences1.2366 of 5 stars$3.66+4.3%N/A+26.2%$4.79M$5.05M-0.8660Positive NewsGap UpCEADCEA IndustriesN/A$16.72+8.2%N/A+108.7%$13.41M$3.28M-3.8330High Trading VolumeSEEDOrigin AgritechN/A$1.13-1.0%N/A-57.0%$8.21M$16.18M0.0060Gap DownEDBLEdible Garden0.9668 of 5 stars$1.79-0.6%N/A-92.4%$5.26M$13.86M-0.0550News CoverageShort Interest ↓Gap DownIVPInspire Veterinary Partners1.5236 of 5 stars$0.90+0.6%N/A-95.7%$3.23M$16.59M-0.08156Positive NewsORISOriental RiseN/A$0.18+35.3%N/AN/A$2.97M$15.01M0.00N/ANews CoveragePositive NewsGap DownHigh Trading VolumeSISISHINECO0.0926 of 5 stars$6.59+8.2%N/A-98.2%$2.53M$9.80M0.0070Gap UpSANWS&W Seed3.2588 of 5 stars$0.34+1.5%$25.00+7,231.4%-92.7%$732K$54.99M-0.02180Positive NewsUpcoming EarningsShort Interest ↓Gap DownYTENYield10 BioscienceN/AN/AN/AN/A$257K$60K0.0030AAGRAfrican AgricultureN/A$0.01+2.0%N/A-95.9%$47K$1.75M0.0085Gap UpAAGRWAfrican AgricultureN/AN/AN/AN/A$0.00$1.75M0.0085 Related Companies and Tools Related Companies CEAD Competitors SEED Competitors EDBL Competitors IVP Competitors ORIS Competitors SISI Competitors SANW Competitors YTEN Competitors AAGR Competitors AAGRW Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RKDA) was last updated on 9/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredThis is the “End of Tesla” as we know it…Jeff has identified five of the past seven number-one performing tech stocks — before they took off. His Tesla...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arcadia Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arcadia Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
